Estrogen Receptor Negative Active Not Recruiting Phase 1 Trials for Everolimus (DB01590)

IndicationStatusPhase
DBCOND0036417 (Estrogen Receptor Negative)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02120469Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast CancerTreatment